Human fused NKG2D–IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells
出版年份 2015 全文链接
标题
Human fused NKG2D–IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells
作者
关键词
-
出版物
Cellular & Molecular Immunology
Volume 14, Issue 3, Pages 293-307
出版商
Springer Nature
发表日期
2015-09-14
DOI
10.1038/cmi.2015.81
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
- (2014) M. Imamura et al. BLOOD
- Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas
- (2014) Dong-xu Zhao et al. CELLULAR IMMUNOLOGY
- Preassociation of IL-15 with IL-15R -IgG1-Fc Enhances Its Activity on Proliferation of NK and CD8+/CD44high T Cells and Its Antitumor Action
- (2014) S. Dubois et al. JOURNAL OF IMMUNOLOGY
- Treatment With a Fusion Protein of the Extracellular Domains of NKG2D to IL-15 Retards Colon Cancer Growth in Mice
- (2014) Yan Xia et al. JOURNAL OF IMMUNOTHERAPY
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- CD4+ NKG2D+T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1εtransgenic mice
- (2013) Zhijie Lin et al. IMMUNOLOGY
- Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
- (2013) Guranda Chitadze et al. INTERNATIONAL JOURNAL OF CANCER
- Epidermal IL-15Rα acts as an endogenous antagonist of psoriasiform inflammation in mouse and man
- (2013) Grégory Bouchaud et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-15 Improves the Cytotoxicity of Cytokine-induced Killer Cells Against Leukemia Cells by Upregulating CD3+CD56+ Cells and Downregulating Regulatory T Cells As Well As IL-35
- (2013) Qianshan Tao et al. JOURNAL OF IMMUNOTHERAPY
- Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
- (2013) G. Chitadze et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- New prospects on the NKG2D/NKG2DL system for oncology
- (2013) Evelyn Ullrich et al. OncoImmunology
- Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia
- (2012) T. A. Waldmann et al. BLOOD
- Regulating the immune system via IL-15 transpresentation
- (2012) Eliseo F. Castillo et al. CYTOKINE
- Targeting NKG2D in tumor surveillance
- (2012) Yoshihiro Hayakawa EXPERT OPINION ON THERAPEUTIC TARGETS
- Paracrine and Transpresentation Functions of IL-15 Are Mediated by Diverse Splice Versions of IL-15Rα in Human Monocytes and Dendritic Cells
- (2012) Jürgen R. Müller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Antibody Fusion Protein for Cancer Immunotherapy Mimicking IL-15 trans -Presentation at the Tumor Site
- (2012) Vanessa Kermer et al. MOLECULAR CANCER THERAPEUTICS
- Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation
- (2011) Isabel Barao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cancer Immunotherapy Using a Bispecific NK Receptor Fusion Protein that Engages both T Cells and Tumor Cells
- (2011) T. Zhang et al. CANCER RESEARCH
- Interleukin 15 as a promising candidate for tumor immunotherapy
- (2011) Marek Jakobisiak et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo
- (2011) N. D. Huntington et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-15 biology and its therapeutic implications in cancer
- (2011) Jason C. Steel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15
- (2010) W. Gong et al. TISSUE ANTIGENS
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells
- (2009) Shomyseh Sanjabi et al. IMMUNITY
- Normally occurring NKG2D+CD4+T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus
- (2009) Zhenpeng Dai et al. JOURNAL OF EXPERIMENTAL MEDICINE
- High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor fusion protein, in metastatic melanoma and colorectal cancer
- (2009) A. Bessard et al. MOLECULAR CANCER THERAPEUTICS
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation
- (2008) Cai Zhang et al. CYTOKINE
- Soluble NKG2D ligands: prevalence, release, and functional impact
- (2008) Helmut Rainer Salih Frontiers in Bioscience-Landmark
- Twelve immunotherapy drugs that could cure cancers
- (2008) Martin A. ‘Mac’ Cheever IMMUNOLOGICAL REVIEWS
- The Exon-3-Encoded Domain of IL-15Rα Contributes to IL-15 High-Affinity Binding and Is Crucial for the IL-15 Antagonistic Effect of Soluble IL-15Rα
- (2008) Grégory Bouchaud et al. JOURNAL OF MOLECULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now